Sentinel Lymph Node Biopsy in Colon Cancer: an Institutional Experience

  • Naresh Kumar SaidhaEmail author
  • Ritu Mehta
  • Munish Malhotra
  • A. K. Singh
  • Deepankar Kumar
  • Chandra Prakash Sharma
Original Article


Lymph node staging is a major prognostic factor in colorectal cancer and remains to be the most important criterion for selecting patients for adjuvant therapy. The standard approach for lymph node evaluation is based on manual dissection and histological evaluation of HE-stained slides. For stage III disease (node positive), adjuvant chemotherapy increases the survival rate, while in node-negative stage II disease, in most cases, the chemotherapy is contraindicated due to increased morbidity without real benefit. Up to 30% of patients with node-negative colon cancer staged by standard pathologic techniques ultimately suffer disease recurrence and tumour-related mortality following potentially curative primary resection. Variations in outcome among patients with node-negative early-stage disease may reflect inadequate nodal resection and inaccuracies of pathologic staging. Hence, an accurate pN stage becomes essential. It is seen that classic pathological exam sometimes fails to identify lymph node micrometastases or isolated tumour cells, which might explain local or distant relapses in stage II patients. Sentinel lymph node study has the potential to detect micrometastases and lead to upstaging the disease which is crucial for planning adjuvant therapy and follow-up in these patients. In our study, we carried out SLNB in 40 clinically stage II patients operated for colon cancer. We used peritumoural injection of dye at the time of surgery to detect SLN(s) and analysed them using both microsectioning and immunohistochemical (IHC) staining. Our results show that SLNB can improve the accuracy of pTNM staging.


Colon cancer Sentinel lymph node biopsy Immunohistochemistry (IHC) 


Compliance with Ethical Standards

This study was cleared by the Ethics Committee, and patient consent obtained in all cases.


  1. 1.
    Bembenek AE, Rosenberg R, Wagler E, Gretschel S, Sendler A, Siewert JR, Nährig J, Witzigmann H, Hauss J, Knorr C, Dimmler A, Gröne J, Buhr HJ, Haier J, Herbst H, Tepel J, Siphos B, Kleespies A, Koenigsrainer A, Stoecklein NH, Horstmann O, Grützmann R, Imdahl A, Svoboda D, Wittekind C, Schneider W, Wernecke KD, Schlag PM (2007) Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg 245:858–863CrossRefGoogle Scholar
  2. 2.
    Joosten JJ, Strobbe LJ, Wauters CA, Pruszczynski M, Wobbes T, Ruers TJ (1999) Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 86(4):482–486CrossRefGoogle Scholar
  3. 3.
    Yang Y, Wang G, He J, Zhang J, Xi J, Wang F (2018) High tie versus low tie of the inferior mesenteric artery in colorectal cancer: a meta-analysis. Int J Surg 52:20–24CrossRefGoogle Scholar
  4. 4.
    Paramo JC, Summerall J, Poppiti R, Mesko TW (2002) Validation of sentinel lymph node mapping in patients with colon cancer. Ann Surg Oncol 9:550–554CrossRefGoogle Scholar
  5. 5.
    Bertagnolli M, Miedema B, Redston M, Dowell J, Niedzwiecki D, Fleshman J, Bem J, Mayer R, Zinner M, Compton C (2004) Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann Surg 240(4):624–628 discussion 628–630Google Scholar
  6. 6.
    Saha S, Seghal R, Patel M, Doan K, Dan A, Bilchik A, Beutler T, Wiese D, Bassily N, Yee C (2006) A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence. Am J Surg 191:305–310CrossRefGoogle Scholar
  7. 7.
    Hennedige T, Teo L, Ang B, Cheong WK, Venkatesh SK (2010) Accuracy of preoperative CT for local staging of colorectal carcinomas. Singap Med J 51(6):475–480Google Scholar
  8. 8.
    Bertoglio S, Sandrucci S, Percivale P, Goss M, Gipponi M, Moresco L, Mussa B, Mussa A (2004) Prognostic value of sentinel lymph node biopsy in the pathologic staging of colorectal cancer patients. J Surg Oncol 85(3):166–170CrossRefGoogle Scholar
  9. 9.
    Nicastri DG, Doucette JT, Godfrey TE, Hughes SJ (2007) Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn 9:563–571CrossRefGoogle Scholar
  10. 10.
    Oh SY, Kim do Y, Kim YB, Suh KW (2014) Clinical application of sentinel lymph node mapping in colon cancer: in vivo vs. ex vivo techniques. Ann Surg Treat Res 87(3):118–122CrossRefGoogle Scholar
  11. 11.
    Cabanas RM (1977) An approach for the treatment of penile carcinoma. Cancer 9:456–466CrossRefGoogle Scholar
  12. 12.
    Bilchik AJ, Hoon DS, Saha S, Turner RR, Wiese D, DiNome M, Koyanagi K, McCarter M, Shen P, Iddings D et al (2007) Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg 246:568–575 discussion 575-577CrossRefGoogle Scholar
  13. 13.
    Natsugoe S, Mueller J, Stein HJ, Feith M, Hofler H, Siewert JR (1998) Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: frequency,associated tumor characteristics, and impact on prognosis. Cancer 83:858–866CrossRefGoogle Scholar
  14. 14.
    Adell G, Boeryd B, Franlund B, Sjodahl R, Hakansson L (1996) Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes’ B colorectal carcinoma: an immunohistochemical study. Eur J Surg 162:637–642Google Scholar
  15. 15.
    Gusterson BA, Ott R (1990) Occult axillary lymph-node micrometastases in breast cancer. Lancet 336:434–435CrossRefGoogle Scholar
  16. 16.
    Croner RS, Geppert CI, Bader FG, Nitsche U, Späth C, Rosenberg R, Zettl A, Matias-Guiu X, Tarragona J, Güller U, Stürzl M, Zuber M (2014) Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study. Br J Cancer 110(10):2544–2550CrossRefGoogle Scholar
  17. 17.
    Nordgård O, Oltedal S, Kørner H, Aasprong OG, Tjensvoll K, Gilje B, Heikkilä R (2009) Quantitative RT-PCR detection of tumor cells in sentinel lymph nodes isolated from colon cancer patients with an ex vivo approach. Ann Surg 249(4):602–607CrossRefGoogle Scholar
  18. 18.
    Des Guetz G, Uzzan B, Nicolas P, Cucherat M, de Mestier P, Morere JF, Breau JL, Perret G (2007) Is sentinel lymph node mapping in colorectal cancer a future prognostic factor? A meta-analysis. World J Surg 31:1304–1312CrossRefGoogle Scholar

Copyright information

© Indian Association of Surgical Oncology 2019

Authors and Affiliations

  1. 1.INHS AsviniMumbaiIndia

Personalised recommendations